Brickell Biotech, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
21 Pages - GLDATA54239
$250.00

Summary

Brickell Biotech, Inc. (Brickell Biotech) is a clinical-stage pharmaceutical company that focuses on the development of therapeutics for the treatment of skin diseases. The company develops novel therapeutics for the treatment of various dermatological diseases such as hyperhidrosis, atopic dermatitis, contact dermatitis and acne. Its product portfolio comprises four product candidates namely, BBI-4000, an anticholinergic in Phase IIb clinical trials for the treatment of primary axillary (underarm) hyperhidrosis; BBI-5000, a selective oral immunomodulator in Phase I clinical trials for moderate to severe atopic dermatitis; BBI-2111, a novel anti-inflammatory small peptide in pre-clinical stage for contact dermatitis; and BBI-3000, a novel potent topical/oral retinoid in pre-clinical stage for the treatment of acne. Brickell Biotech is headquartered in Miami, Florida, the US.

Brickell Biotech, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Brickell Biotech, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Brickell Biotech Acquires Rights to RORy Inhibitors from Orca Pharma 10
Venture Financing 11
Brickell Biotech Raises USD10 Million in Series C Financing 11
Brickell Biotech Raises US$7 Million In Series B Financing 12
Brickell Biotech Raises US$6.2 Million In Venture Financing 14
Licensing Agreements 15
Brickell Biotech Enters into Licensing Agreement with Kaken Pharma 15
Brickell Biotech Enters into Licensing Agreement with Merz North America for BBI-3000 16
Argyle Therapeutics Enters Into Licensing Agreement With Brickell Biotech For Rosacea Drug 17
Brickell Biotech, Inc. - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Key Facts 1
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Brickell Biotech, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Brickell Biotech, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Brickell Biotech Acquires Rights to RORy Inhibitors from Orca Pharma 10
Brickell Biotech Raises USD10 Million in Series C Financing 11
Brickell Biotech Raises US$7 Million In Series B Financing 12
Brickell Biotech Raises US$6.2 Million In Venture Financing 14
Brickell Biotech Enters into Licensing Agreement with Kaken Pharma 15
Brickell Biotech Enters into Licensing Agreement with Merz North America for BBI-3000 16
Argyle Therapeutics Enters Into Licensing Agreement With Brickell Biotech For Rosacea Drug 17
Brickell Biotech, Inc., Key Competitors 18
Brickell Biotech, Inc., Key Employees 19

List of Figures
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Brickell Biotech, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838